{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:41:53Z","timestamp":1788871313353,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100001458","name":"American Kennel Club Canine Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001458","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Status epilepticus (SE) and acute repetitive seizures (ARS) are common canine neurologic emergencies. No evidence-based studies are available to guide treatment in veterinary patients. Parenteral levetiracetam (LEV) has many favorable properties for the emergency treatment of seizures, but its safety and efficacy in dogs for SE and ARS are unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Intravenous LEV is superior to placebo in controlling seizures in dogs with SE or ARS after treatment with IV diazepam.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Nineteen client-owned dogs admitted for SE or ARS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Randomized, placebo-controlled, double-masked study. Dogs with SE or ARS were randomized to receive IV LEV (30 or 60\u00a0mg\/kg using an adaptive dose-escalation approach) or placebo, in addition to standard of care treatment. They were monitored for at least 24\u00a0hours after admission for additional seizures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The responder rate (defined as dogs with no additional seizures after administration of the study medication) after LEV was 56% compared with 10% for placebo (P\u00a0=\u00a0.06). Dogs in the placebo group required significantly more boluses of diazepam compared with the LEV group (P\u00a0&amp;lt;\u00a0.03). Seizure etiologies identified were idiopathic epilepsy (n\u00a0=\u00a010), inflammatory central nervous system disease (n\u00a0=\u00a04), intracranial neoplasia (n\u00a0=\u00a02), hepatic encephalopathy (n\u00a0=\u00a01), and 2 dogs had no cause determined. No serious adverse effects were attributable to LEV administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>LEV was safe and potentially effective for the treatment of SE and ARS in these client-owned dogs. Larger, controlled clinical trials are needed to confirm this preliminary observation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2011.00868.x","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T05:36:37Z","timestamp":1328074597000},"page":"334-340","source":"Crossref","is-referenced-by-count":68,"title":["Double-Masked, Placebo-Controlled Study of Intravenous Levetiracetam for the Treatment of Status Epilepticus and Acute Repetitive Seizures in Dogs"],"prefix":"10.1093","volume":"26","author":[{"given":"B.T.","family":"Hardy","sequence":"first","affiliation":[{"name":"Veterinary Clinical Sciences, University of Minnesota , Saint Paul, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. E.","family":"Patterson","sequence":"additional","affiliation":[{"name":"Veterinary Clinical Sciences, University of Minnesota , Saint Paul, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Cloyd","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Pharmacology, University of Minnesota , Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Hardy","sequence":"additional","affiliation":[{"name":"Veterinary Clinical Sciences, University of Minnesota , Saint Paul, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.E.","family":"Leppik","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Pharmacology, University of Minnesota , Minneapolis, MN"},{"name":"University of Minnesota Department of Neurology,"},{"name":"MINCEP Epilepsy Care , Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,3,1]]},"reference":[{"key":"2026020600172369800_jvim868-bib-0001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1748-5827.2002.tb00047.x","article-title":"Canine status epilepticus: A retrospective study of 50 cases","volume":"43","author":"Platt","year":"2002","journal-title":"J Small Anim Pract"},{"key":"2026020600172369800_jvim868-bib-0002","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2460\/javma.2001.219.618","article-title":"Risk factors for development of status epilepticus in dogs with idiopathic epilepsy and effects of status epilepticus on outcome and survival time: 32 cases (1990-1996)","volume":"219","author":"Saito","year":"2001","journal-title":"J Am Vet Med Assoc"},{"key":"2026020600172369800_jvim868-bib-0003","doi-asserted-by":"crossref","first-page":"s59","DOI":"10.1111\/j.1528-1157.1999.tb00880.x","article-title":"Management approaches to prolonged seizures and status epilepticus","volume":"40","author":"Bleck","year":"1999","journal-title":"Epilepsia"},{"key":"2026020600172369800_jvim868-bib-0004","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-0404.2008.01097.x","article-title":"Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin","volume":"118","author":"Gilad","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"2026020600172369800_jvim868-bib-0005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.yebeh.2007.12.013","article-title":"An alternative perspective on the management of status epilepticus","volume":"12","author":"Beran","year":"2008","journal-title":"Epilepsy Behav"},{"key":"2026020600172369800_jvim868-bib-0006","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2460\/javma.1999.215.10.1463","article-title":"Clinical findings, treatment, and outcome of dogs with status epilepticus or cluster seizures: 156 cases (1990-1995)","volume":"215","author":"Bateman","year":"1999","journal-title":"J Am Vet Med Assoc"},{"key":"2026020600172369800_jvim868-bib-0007","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1939-1676.2009.0368.x","article-title":"Status epilepticus and epileptic seizures in dogs","volume":"23","author":"Zimmermann","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020600172369800_jvim868-bib-0008","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1468-1331.2004.00943.x","article-title":"A systematic review of the epidemiology of status epilepticus","volume":"11","author":"Chin","year":"2004","journal-title":"Eur J Neurol"},{"key":"2026020600172369800_jvim868-bib-0009","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1212\/WNL.46.4.1029","article-title":"A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia","volume":"46","author":"DeLorenzo","year":"1996","journal-title":"Neurology"},{"key":"2026020600172369800_jvim868-bib-0010","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.1983.03330350028021","article-title":"Double-blind study of lorazepam and diazepam in status epilepticus","volume":"249","author":"Leppik","year":"1983","journal-title":"J Am Med Assoc"},{"key":"2026020600172369800_jvim868-bib-0011","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa002141","article-title":"A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus","volume":"345","author":"Alldredge","year":"2001","journal-title":"N Eng J Med"},{"key":"2026020600172369800_jvim868-bib-0012","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Eng J Med"},{"key":"2026020600172369800_jvim868-bib-0013","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1528-1167.2011.03056.x","article-title":"Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam","volume":"52","author":"Alvarez","year":"2011","journal-title":"Epilepsia"},{"key":"2026020600172369800_jvim868-bib-0014","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1600-0404.2010.01351.x","article-title":"Intravenous levetiracetam as first-line treatment of status epilepticus in the elderly","volume":"121","author":"Fattouch","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"2026020600172369800_jvim868-bib-0015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/35087000","article-title":"SV2 modulates the size of the readily releasable pool of secretory vesicles","volume":"3","author":"Xu","year":"2001","journal-title":"Nat Cell Biol"},{"key":"2026020600172369800_jvim868-bib-0016","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020600172369800_jvim868-bib-0017","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1527-3458.2007.00005.x","article-title":"Levetiracetam: Part II, the clinical profile of a novel anticonvulsant drug","volume":"13","author":"De Smedt","year":"2007","journal-title":"CNS Drug Rev"},{"key":"2026020600172369800_jvim868-bib-0018","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2885.2008.00948.x","article-title":"Intramuscular, intravenous and oral levetiracetam in dogs: Safety and pharmacokinetics","volume":"31","author":"Patterson","year":"2008","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020600172369800_jvim868-bib-0019","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1476-4431.2008.00294.x","article-title":"Pharmacokinetics of single-dose intravenous levetiracetam administration in normal dogs","volume":"18","author":"Dewey","year":"2008","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020600172369800_jvim868-bib-0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0920-1211(98)00104-1","article-title":"Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat","volume":"34","author":"Doheny","year":"1999","journal-title":"Epilepsy Res"},{"key":"2026020600172369800_jvim868-bib-0021","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bjp.0704141","article-title":"A microdialysis study of the novel antiepileptic drug levetiracetam: Extracellular pharmacokinetics and effect on taurine in rat brain","volume":"133","author":"Tong","year":"2001","journal-title":"Br J Pharmacol"},{"key":"2026020600172369800_jvim868-bib-0022","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cvsm.2009.09.004","article-title":"Idiopathic epilepsy in dogs and cats","volume":"40","author":"Thomas","year":"2010","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020600172369800_jvim868-bib-0023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: Toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol Ther"},{"key":"2026020600172369800_jvim868-bib-0024","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00127893-200203000-00002","article-title":"New antiepileptic drugs","volume":"8","author":"Bazil","year":"2002","journal-title":"Neurologist"},{"key":"2026020600172369800_jvim868-bib-0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2885.2010.01188.x","article-title":"The pharmacokinetics of levetiracetam in healthy dogs concurrently receiving phenobarbital","volume":"34","author":"Moore","year":"2011","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020600172369800_jvim868-bib-0026","first-page":"606","article-title":"Status epilepticus","volume":"1","author":"Indrieri","year":"1989","journal-title":"Probl Vet Med"},{"key":"2026020600172369800_jvim868-bib-0027","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1939-1676.2006.tb02841.x","article-title":"Use of ketamine for the management of refractory status epilepticus in a dog","volume":"20","author":"Serrano","year":"2006","journal-title":"J Vet Intern Med"},{"key":"2026020600172369800_jvim868-bib-0028","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/B978-1-4160-2591-7.10098-0","volume-title":"Small Animal Critical Care Medicine","author":"Vernau","year":"2009"},{"key":"2026020600172369800_jvim868-bib-0029","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1748-5827.2000.tb03971.x","article-title":"Propofol for treatment of refractory seizures in dogs and a cat with intracranial disorders","volume":"41","author":"Steffen","year":"2000","journal-title":"J Small Anim Pract"},{"key":"2026020600172369800_jvim868-bib-0030","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1212\/WNL.29.11.1474","article-title":"Intravenous phenytoin in acute treatment of seizures","volume":"29","author":"Cranford","year":"1979","journal-title":"Neurology"},{"issue":"2","key":"2026020600172369800_jvim868-bib-0031","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1528-1167.2009.02362.x","article-title":"Canine status epilepticus: Proof of principle studies","volume":"50","author":"Leppik","year":"2009","journal-title":"Epilepsia"},{"key":"2026020600172369800_jvim868-bib-0032","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1528-1157.1998.tb01177.x","article-title":"Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus","volume":"39","author":"DeLorenzo","year":"1998","journal-title":"Epilepsia"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2011.00868.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/26\/2\/334\/66683199\/jvim868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/26\/2\/334\/66683199\/jvim868.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:17:31Z","timestamp":1770355051000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/26\/2\/334\/8451559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2011.00868.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,3]]},"published":{"date-parts":[[2012,3,1]]}}}